関連する実験動画

Updated: Jun 15, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.2K

メタボリック・プロファイリングは,明確な予後と治療的脆弱性を持つ膠芽細胞腫のサブタイプを定義する

Fan Wu1,2,3, Yi-Yun Yin1,2,3, Di Wang1,2,3

  • 1Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, 100070, China.

Neuro-oncology
|January 4, 2026
PubMed
まとめ

No abstract available in PubMed .

キーワード:
グリオブラストーマメタボリックプロファイリング分子型マルチオミクス予測

さらに関連する動画

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

6.2K
Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

374

関連する概念動画

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...